Company
Adverum Biotechnologies
Adverum Biotechnologies has 4 drugs tracked on RxWires: 1 in Phase 3, 2 in Phase 2, 1 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Ixo-vec | Phase 3 | Neovascular Age-Related Macular Degeneration (nAMD) |
| 6E11 vg/eye of ADVM-022 | Phase 2 | Diabetic Macular Edema |
| ADVM-022 | Phase 2 | Neovascular Age-related Macular Degeneration |
| ADVM-043 | Phase 1/2 | Alpha 1-Antitrypsin Deficiency |
Latest
No recent events.
Follow Adverum Biotechnologies on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.